Intravitreal Dexamethasone Implant versus Intravitreal Ranibizumab for the Treatment of Macular Edema Secondary to Retinal Vein Occlusion in a Chinese Population

Publisher： Karger

E-ISSN： 1423-0259|58|1|8-14

ISSN： 0030-3747

Source： Ophthalmic Research, Vol.58, Iss.1, 2017-03, pp. : 8-14

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Intravitreal Ranibizumab and/or Dexamethasone Implant for Macular Edema Secondary to Retinal Vein Occlusion

By  

Ophthalmologica, Vol. 232, Iss. 4, 2014-11 ,pp. : 216-222

Karger

Access to resources Recommend Favorite

Comparison of Intravitreal Bevacizumab Upload Followed by a Dexamethasone Implant versus Dexamethasone Implant Monotherapy for Retinal Vein Occlusion with Macular Edema

By  

Ophthalmologica, Vol. 228, Iss. 2, 2012-06 ,pp. : 110-116

Karger

Access to resources Recommend Favorite

Intravitreal Ranibizumab for Macular Edema Secondary to Retinal Vein Occlusion

By  

Ophthalmologica, Vol. 227, Iss. 3, 2011-12 ,pp. : 132-138

Karger

Access to resources Recommend Favorite

Intravitreal Ranibizumab versus Isovolemic Hemodilution in the Treatment of Macular Edema Secondary to Central Retinal Vein Occlusion: Twelve-Month Results of a Prospective, Randomized, Multicenter Trial

By  

Ophthalmologica, Vol. 233, Iss. 1, 2014-12 ,pp. : 8-17

Karger

Access to resources Recommend Favorite

Intravitreal Dexamethasone Implant for Macular Edema Secondary to Retinal Vein Occlusion: 12-month Follow-Up and Prognostic Factors

By  

Ophthalmologica, Vol. 232, Iss. 4, 2014-11 ,pp. : 207-215

Karger

Access to resources Recommend Favorite